Positive	O
and	O
negative	O
regulation	O
of	O
IL-2	B-protein
gene	O
expression	O
:	O
role	O
of	O
multiple	O
regulatory	O
sites	O
.	O

Interleukin	O
2	O
(	O
IL-2	B-protein
)	O
is	O
an	O
important	O
lymphokine	B-protein
required	O
in	O
the	O
process	O
of	O
T	O
cell	O
activation	O
,	O
proliferation	O
,	O
clonal	O
expansion	O
and	O
differentiation	O
.	O

The	O
IL-2	B-DNA
gene	I-DNA
displays	O
both	O
T	O
cell	O
specific	O
and	O
inducible	O
expression	O
:	O
it	O
is	O
only	O
expressed	O
in	O
CD4+	B-cell_type
T	I-cell_type
cells	I-cell_type
after	O
antigenic	O
or	O
mitogenic	O
stimulation	O
.	O

Several	O
cis-acting	B-DNA
regulatory	I-DNA
sites	I-DNA
are	O
required	O
for	O
induction	O
of	O
the	O
IL-2	B-DNA
gene	I-DNA
after	O
stimulation	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
analysed	O
the	O
function	O
of	O
these	O
cis-acting	B-DNA
regulatory	I-DNA
sites	I-DNA
in	O
the	O
context	O
of	O
the	O
native	O
IL-2	B-DNA
enhancer	I-DNA
and	O
promoter	B-DNA
sequence	I-DNA
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
the	O
NFAT	B-protein
(	O
-276	B-DNA
to	I-DNA
-261	I-DNA
)	O
,	O
the	O
distal	B-DNA
octamer	I-DNA
(	O
-256	B-DNA
to	I-DNA
-248	I-DNA
)	O
and	O
the	O
proximal	B-DNA
octamer	I-DNA
(	O
-75	B-DNA
to	I-DNA
-66	I-DNA
)	O
sites	O
not	O
only	O
act	O
as	O
enhancers	O
of	O
IL-2	B-DNA
gene	I-DNA
transcription	O
in	O
the	O
presence	O
of	O
cellular	O
stimulation	O
,	O
but	O
also	O
have	O
a	O
silencing	O
effect	O
on	O
IL-2	B-DNA
gene	I-DNA
expression	O
in	O
resting	O
cells	O
.	O

Two	O
other	O
sites	O
display	O
disparate	O
effects	O
on	O
IL-2	B-DNA
gene	I-DNA
expression	O
in	O
different	O
T	B-cell_line
leukemia	I-cell_line
cell	I-cell_line
lines	I-cell_line
:	O
the	O
distal	B-DNA
purine	I-DNA
box	I-DNA
(	O
-291	B-DNA
to	I-DNA
-277	I-DNA
)	O
and	O
the	O
proximal	B-DNA
purine	I-DNA
box	I-DNA
sites	I-DNA
(	O
-145	B-DNA
to	I-DNA
-128	I-DNA
)	O
.	O

Finally	O
,	O
the	O
AP-1	B-DNA
(	I-DNA
-186	I-DNA
to	I-DNA
-176	I-DNA
)	I-DNA
and	I-DNA
the	I-DNA
kappa	I-DNA
B	I-DNA
sites	I-DNA
(	O
-206	B-DNA
to	I-DNA
-195	I-DNA
)	O
respond	O
to	O
different	O
cellular	O
activation	O
in	O
EL4	B-cell_line
cells	I-cell_line
.	O

The	O
AP-1	B-DNA
site	I-DNA
mediated	O
the	O
response	O
to	O
PMA	O
stimulation	O
while	O
the	O
kappa	B-DNA
B	I-DNA
site	I-DNA
responded	O
to	O
IL-1	B-protein
stimulation	O
.	O

These	O
data	O
suggest	O
that	O
the	O
regulation	O
of	O
IL-2	B-DNA
gene	I-DNA
expression	O
is	O
a	O
complex	O
process	O
and	O
multiple	O
cis-acting	B-DNA
regulatory	I-DNA
sites	I-DNA
interact	O
to	O
exert	O
different	O
effects	O
in	O
T	B-cell_type
cells	I-cell_type
representative	O
of	O
alternative	O
stages	O
of	O
differentiation	O
.	O

POSITIVE	NULL
AND	NULL
NEGATIVE	NULL
REGULATION	NULL
OF	NULL
IL-2	NULL
GENE	NULL
EXPRESSION	NULL
:	NULL
ROLE	NULL
OF	NULL
MULTN	NULL
E	NULL
REGULATORY	NULL
SITES	NULL
Liqian	NULL
Zhang	NULL
and	NULL
Gary	NULL
J.	NULL
Nabel	NULL
Interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
is	NULL
an	NULL
important	NULL
lymphokine	NULL
required	NULL
in	NULL
the	NULL
process	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
proliferation	NULL
,	NULL
clonal	NULL
expansion	NULL
and	NULL
differentiation	NULL
.	NULL

The	NULL
IL-2	NULL
gene	NULL
displays	NULL
both	NULL
T	NULL
cell	NULL
specific	NULL
and	NULL
inducible	NULL
expression	NULL
:	NULL
it	NULL
is	NULL
only	NULL
expressed	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
after	NULL
antigenic	NULL
or	NULL
mitogenic	NULL
stimulation	NULL
.	NULL

Several	NULL
cis-acting	NULL
regulatory	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
after	NULL
stimulation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
analysed	NULL
the	NULL
function	NULL
of	NULL
these	NULL
cis-acting	NULL
regulatory	NULL
sites	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
native	NULL
IL-2	NULL
enhancer	NULL
and	NULL
promoter	NULL
sequence	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
study	NULL
suggest	NULL
that	NULL
the	NULL
NFAT	NULL
(	NULL
-276	NULL
to	NULL
-261	NULL
)	NULL
,	NULL
the	NULL
distal	NULL
octamer	NULL
(	NULL
-256	NULL
to	NULL
-248	NULL
)	NULL
and	NULL
the	NULL
proximal	NULL
octamer	NULL
(	NULL
-75	NULL
to	NULL
-66	NULL
)	NULL
sites	NULL
not	NULL
only	NULL
act	NULL
as	NULL
enhancers	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cellular	NULL
stimulation	NULL
,	NULL
but	NULL
also	NULL
have	NULL
a	NULL
silencing	NULL
effect	NULL
on	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

Two	NULL
other	NULL
sites	NULL
display	NULL
disparate	NULL
effects	NULL
on	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
different	NULL
T	NULL
leukemia	NULL
cell	NULL
lines	NULL
:	NULL
the	NULL
distal	NULL
purine	NULL
box	NULL
(	NULL
-291	NULL
to	NULL
-277	NULL
)	NULL
and	NULL
the	NULL
proximal	NULL
purine	NULL
box	NULL
sites	NULL
(	NULL
-145	NULL
to	NULL
-128	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
AP-1	NULL
(	NULL
-186	NULL
to	NULL
-176	NULL
)	NULL
and	NULL
the	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
-206	NULL
to	NULL
-195	NULL
)	NULL
respond	NULL
to	NULL
different	NULL
cellular	NULL
activation	NULL
in	NULL
EL4	NULL
cells	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
mediated	NULL
the	NULL
response	NULL
to	NULL
PMA	NULL
stimulation	NULL
while	NULL
the	NULL
«	NULL
B	NULL
site	NULL
responded	NULL
to	NULL
IL-1	NULL
stimulation	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
is	NULL
a	NULL
complex	NULL
process	NULL
and	NULL
multiple	NULL
cis-acting	NULL
regulatory	NULL
sites	NULL
interact	NULL
to	NULL
exert	NULL
different	NULL
effects	NULL
in	NULL
T	NULL
cells	NULL
representative	NULL
of	NULL
alternative	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

Interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
is	NULL
a	NULL
15	NULL
kDa	NULL
glycoprotein	NULL
``	NULL
produced	NULL
by	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
after	NULL
mitogenic	NULL
or	NULL
antigenic	NULL
stimulation	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
crucial	NULL
to	NULL
the	NULL
function	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
(	NULL
IL-2r	NULL
)	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
is	NULL
required	NULL
for	NULL
antigen-specific	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
activated	NULL
B	NULL
cells	NULL
into	NULL
antibody-secreting	NULL
cells	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
cytotoxicity	NULL
by	NULL
cytotoxic	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

``	NULL
~*	NULL
Expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
restricted	NULL
to	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
regulatory	NULL
sequence	NULL
for	NULL
the	NULL
IL-2	NULL
gene	NULL
lie	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
the	NULL
region	NULL
from	NULL
-326	NULL
to	NULL
-52	NULL
(	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
transfected	NULL
IL-2	NULL
reporter	NULL
plasmids	NULL
in	NULL
mitogen	NULL
induced	NULL
From	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
,	NULL
Departments	NULL
of	NULL
Internal	NULL
Medicine	NULL
and	NULL
Biological	NULL
Chemistry	NULL
,	NULL
1150	NULL
West	NULL
Medical	NULL
Center	NULL
Drive	NULL
,	NULL
4510	NULL
MSRB	NULL
I	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
48109-0650	NULL
,	NULL
USA	NULL
.	NULL

Correspondence	NULL
to	NULL
:	NULL
Gary	NULL
J.	NULL
Nabel	NULL
.	NULL

Received	NULL
9	NULL
July	NULL
1993	NULL
;	NULL
revised	NULL
and	NULL
accepted	NULL
for	NULL
publication	NULL
29	NULL
October	NULL
1993	NULL
©	NULL
1994	NULL
Academic	NULL
Press	NULL
Limited	NULL
1043-4666/94/030221	NULL
+08	NULL
$	NULL
08.00/0	NULL
KEY	NULL
WORDS	NULL
:	NULL
Gene	NULL
regulation/Interleukin	NULL
2/T	NULL
cell	NULL
activation	NULL
CYTOKINE	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
May	NULL
)	NULL
,	NULL
1994	NULL
;	NULL
pp	NULL
221-228	NULL
T	NULL
cells	NULL
.	NULL

``	NULL
``	NULL
°	NULL
DNA	NULL
footprinting	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
revealed	NULL
that	NULL
there	NULL
are	NULL
specific	NULL
DNA-protein	NULL
interactions	NULL
at	NULL
the	NULL
NFAT	NULL
site	NULL
(	NULL
-285	NULL
to	NULL
-255	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
octamer	NULL
site	NULL
(	NULL
-83	NULL
to	NULL
-66	NULL
)	NULL
,	NULL
distal	NULL
octamer	NULL
sites	NULL
(	NULL
-256	NULL
to	NULL
-248	NULL
)	NULL
,	NULL
and	NULL
the	NULL
distal	NULL
purine	NULL
box	NULL
site	NULL
(	NULL
-291	NULL
to	NULL
-271	NULL
)	NULL
.	NULL

'~	NULL
``	NULL
``	NULL
A	NULL
«	NULL
B	NULL
site	NULL
(	NULL
-206	NULL
to	NULL
-195	NULL
)	NULL
and	NULL
an	NULL
AP-1	NULL
site	NULL
(	NULL
-186	NULL
to	NULL
-176	NULL
)	NULL
were	NULL
also	NULL
identified	NULL
by	NULL
sequence	NULL
homology	NULL
to	NULL
the	NULL
known	NULL
consensus	NULL
sequences	NULL
.	NULL

Figure	NULL
1	NULL
gives	NULL
a	NULL
simple	NULL
representation	NULL
of	NULL
these	NULL
sites	NULL
and	NULL
their	NULL
location	NULL
.	NULL

In	NULL
most	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
functions	NULL
of	NULL
these	NULL
cis-regulatory	NULL
sites	NULL
were	NULL
determined	NULL
through	NULL
deletion	NULL
experiments	NULL
or	NULL
by	NULL
linking	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
site	NULL
of	NULL
interest	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
or	NULL
enhancer	NULL
.	NULL

Although	NULL
this	NULL
kind	NULL
of	NULL
approach	NULL
is	NULL
simple	NULL
and	NULL
straight-forward	NULL
,	NULL
the	NULL
site	NULL
is	NULL
examined	NULL
out	NULL
of	NULL
its	NULL
native	NULL
context	NULL
,	NULL
and	NULL
the	NULL
interpretation	NULL
of	NULL
these	NULL
results	NULL
may	NULL
not	NULL
reflect	NULL
the	NULL
true	NULL
function	NULL
of	NULL
the	NULL
regulatory	NULL
site	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
functions	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
region	NULL
,	NULL
each	NULL
site	NULL
has	NULL
been	NULL
mutated	NULL
in	NULL
its	NULL
surrounding	NULL
sequences	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

After	NULL
transfecting	NULL
these	NULL
mutants	NULL
into	NULL
either	NULL
Jurkat	NULL
or	NULL
EL4	NULL
cells	NULL
,	NULL
the	NULL
basal	NULL
or	NULL
stimulated	NULL
CAT	NULL
activities	NULL
are	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
native	NULL
IL2-CAT	NULL
plasmid	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
each	NULL
site	NULL
in	NULL
either	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
221	NULL
222	NULL
/	NULL
Zhang	NULL
and	NULL
Nabel	NULL
CYTOKINE	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
May	NULL
1994	NULL
;	NULL
221-228	NULL
)	NULL
Distal	NULL
Pu-box	NULL
NFAT	NULL
distal	NULL
oct	NULL
x	NULL
B	NULL
AP-1	NULL
J_	NULL
]	NULL
l	NULL
|	NULL
_|	NULL
|	NULL
1	NULL
_	NULL
|	NULL
_|	NULL
f	NULL
_ses	NULL
!	NULL

-zo1	NULL
-277	NULL
-261	NULL
_	NULL
-256	NULL
-248	NULL
-	NULL
-206	NULL
-195	NULL
-186	NULL
-1e	NULL
-	NULL
/	NULL
Proximal	NULL
Pu-box	NULL
Proximal	NULL
oct	NULL
TATA	NULL
l	NULL
I	NULL
l	NULL
l	NULL
I	NULL
]	NULL
l	NULL
CAT	NULL
-145	NULL
-128	NULL
-75	NULL
-66	NULL
-32	NULL
-28	NULL
+1	NULL
+18	NULL
IL2-CAT	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
IL2-CAT	NULL
plasmid	NULL
.	NULL

Each	NULL
box	NULL
represents	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
site	NULL
with	NULL
the	NULL
position	NULL
relative	NULL
to	NULL
transcriptional	NULL
initiation	NULL
site	NULL
underneath	NULL
it	NULL
.	NULL

or	NULL
the	NULL
response	NULL
to	NULL
different	NULL
extracellular	NULL
stimulation	NULL
signals	NULL
.	NULL

Unlike	NULL
previous	NULL
studies	NULL
that	NULL
used	NULL
deletion	NULL
plasmids	NULL
or	NULL
tandem	NULL
copies	NULL
of	NULL
a	NULL
single	NULL
site	NULL
,	NULL
the	NULL
present	NULL
work	NULL
uses	NULL
site-directed	NULL
mutagenesis	NULL
to	NULL
maximally	NULL
preserve	NULL
the	NULL
DNA-protein	NULL
or	NULL
protein-protein	NULL
interac-tion	NULL
,	NULL
making	NULL
interpretation	NULL
of	NULL
each	NULL
site	NULL
's	NULL
functions	NULL
closest	NULL
to	NULL
its	NULL
native	NULL
ones	NULL
.	NULL

The	NULL
results	NULL
we	NULL
report	NULL
here	NULL
show	NULL
that	NULL
all	NULL
seven	NULL
regulatory	NULL
sites	NULL
studied	NULL
appear	NULL
to	NULL
be	NULL
of	NULL
some	NULL
importance	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimulation	NULL
.	NULL

The	NULL
NFAT	NULL
site	NULL
,	NULL
the	NULL
proximal	NULL
octamer	NULL
site	NULL
and	NULL
the	NULL
distal	NULL
octamer	NULL
site	NULL
have	NULL
a	NULL
silencing	NULL
effect	NULL
on	NULL
IL-2	NULL
transcription	NULL
in	NULL
untreated	NULL
cells	NULL
,	NULL
and	NULL
also	NULL
act	NULL
as	NULL
enhancers	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
stimulation	NULL
.	NULL

The	NULL
proximal	NULL
and	NULL
distal	NULL
purine	NULL
box	NULL
sites	NULL
show	NULL
different	NULL
functions	NULL
in	NULL
different	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
the	NULL
«	NULL
B	NULL
site	NULL
and	NULL
the	NULL
AP-1	NULL
site	NULL
respond	NULL
to	NULL
IL-1	NULL
or	NULL
PMA	NULL
stimulation	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
a	NULL
complex	NULL
process	NULL
,	NULL
involving	NULL
the	NULL
responses	NULL
of	NULL
multiple	NULL
regulatory	NULL
sites	NULL
to	NULL
different	NULL
membrane	NULL
signals	NULL
.	NULL

RESULTS	NULL
Proximal	NULL
Octamer	NULL
,	NULL
Distant	NULL
Octamer	NULL
and	NULL
NFAT	NULL
Sites	NULL
By	NULL
sequence	NULL
comparison	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
in	NULL
the	NULL
Ig	NULL
enhancer	NULL
,	NULL
two	NULL
octamer	NULL
sites	NULL
had	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
region	NULL
;	NULL
the	NULL
proximal	NULL
one	NULL
(	NULL
-75	NULL
to	NULL
-66	NULL
)	NULL
has	NULL
the	NULL
same	NULL
orientation	NULL
as	NULL
the	NULL
octamer	NULL
site	NULL
in	NULL
the	NULL
Ig	NULL
enhancer	NULL
while	NULL
the	NULL
distal	NULL
site	NULL
(	NULL
-256	NULL
to	NULL
-248	NULL
)	NULL
is	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
specific	NULL
protein-DNA	NULL
interactions	NULL
between	NULL
the	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
cells	NULL
and	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
the	NULL
proximal	NULL
octamer	NULL
or	NULL
the	NULL
distal	NULL
octamer	NULL
sequence	NULL
,	NULL
and	NULL
one	NULL
of	NULL
the	NULL
components	NULL
in	NULL
this	NULL
protein	NULL
complex	NULL
is	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
,	NULL
Also	NULL
,	NULL
these	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
proximal	NULL
octamer	NULL
site	NULL
is	NULL
a	NULL
negative	NULL
regulatory	NULL
site	NULL
and	NULL
the	NULL
distal	NULL
octamer	NULL
site	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
site	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
the	NULL
functions	NULL
of	NULL
the	NULL
two	NULL
octamer	NULL
sites	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
in	NULL
their	NULL
native	NULL
DNA	NULL
sequence	NULL
context	NULL
,	NULL
single	NULL
or	NULL
double	NULL
octamer	NULL
site	NULL
mutants	NULL
were	NULL
made	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
their	NULL
transient	NULL
expression	NULL
studied	NULL
in	NULL
either	NULL
Jurkat	NULL
or	NULL
ELA	NULL
cells	NULL
.	NULL

The	NULL
basal	NULL
and	NULL
stimulated	NULL
CAT	NULL
activities	NULL
of	NULL
these	NULL
mutants	NULL
were	NULL
compared	NULL
to	NULL
those	NULL
of	NULL
the	NULL
native	NULL
IL2-CAT	NULL
plasmid	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

CAT	NULL
activity	NULL
of	NULL
each	NULL
single	NULL
mutant	NULL
decreased	NULL
23	NULL
%	NULL
to	NULL
88	NULL
%	NULL
after	NULL
cellular	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
verifying	NULL
that	NULL
both	NULL
octamer	NULL
sites	NULL
contribute	NULL
to	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
basal	NULL
activities	NULL
of	NULL
either	NULL
of	NULL
the	NULL
single	NULL
octamer	NULL
site	NULL
mutants	NULL
increased	NULL
by	NULL
6.6-	NULL
to	NULL
16-fold	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
both	NULL
octamer	NULL
sites	NULL
are	NULL
also	NULL
important	NULL
in	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
when	NULL
both	NULL
octamer	NULL
sites	NULL
were	NULL
mutated	NULL
,	NULL
the	NULL
response	NULL
to	NULL
extracellular	NULL
stimulation	NULL
completely	NULL
disappeared	NULL
while	NULL
the	NULL
basal	NULL
activity	NULL
increased	NULL
by	NULL
2.5-	NULL
to	NULL
27.5-fold	NULL
,	NULL
further	NULL
demonstrating	NULL
the	NULL
importance	NULL
of	NULL
both	NULL
octamer	NULL
sites	NULL
in	NULL
the	NULL
negative	NULL
and	NULL
positive	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
both	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
octamer	NULL
sites	NULL
contribute	NULL
individually	NULL
to	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
IL-2	NULL
promoter	NULL
in	NULL
resting	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
stimulation	NULL
.	NULL

Mutation	NULL
of	NULL
both	NULL
sites	NULL
destroyed	NULL
the	NULL
inducible	NULL
function	NULL
entirely	NULL
.	NULL

The	NULL
NFAT	NULL
site	NULL
(	NULL
-289	NULL
to	NULL
-263	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
T	NULL
cell-specific	NULL
factor	NULL
NFAT-1	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
confer	NULL
T	NULL
cell-specific	NULL
,	NULL
inducible	NULL
and	NULL
enhanced	NULL
expression	NULL
upon	NULL
the	NULL
A	NULL
Plasmid	NULL
aoct.pa	NULL
[	NULL
H	NULL
_	NULL
NR	NULL
H	NULL
_	NULL
Stimulation	NULL
Regulatory	NULL
site	NULL
function	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
/	NULL
223	NULL
Percent	NULL
conversion	NULL
0	NULL
10	NULL
20	NULL
830	NULL
40	NULL
50	NULL
60	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
the	NULL
single	NULL
or	NULL
double	NULL
octamer	NULL
site	NULL
mutation	NULL
on	NULL
the	NULL
transient	NULL
expression	NULL
of	NULL
IL2-CAT	NULL
.	NULL

Jurkat	NULL
(	NULL
A	NULL
)	NULL
or	NULL
ELA	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild	NULL
type	NULL
plasmid	NULL
(	NULL
IL2-CAT	NULL
)	NULL
,	NULL
the	NULL
single	NULL
octamer	NULL
site	NULL
mutants	NULL
(	NULL
A	NULL
Oct.p	NULL
,	NULL
or	NULL
A	NULL
Oct.d	NULL
)	NULL
,	NULL
or	NULL
the	NULL
double	NULL
octamer	NULL
site	NULL
mutant	NULL
(	NULL
A	NULL
Oct.p/d	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
stimulation	NULL
.	NULL

Cell	NULL
treatment	NULL
and	NULL
CAT	NULL
activity	NULL
determination	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
order	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1.	NULL
normally	NULL
uninduced	NULL
fibrinogen	NULL
promoter.©	NULL
To	NULL
determine	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
on	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
a	NULL
-277	NULL
to	NULL
-261	NULL
mutant	NULL
IL2-CAT-A	NULL
NFAT	NULL
was	NULL
used	NULL
in	NULL
transfection	NULL
experiments	NULL
.	NULL

Similar	NULL
results	NULL
to	NULL
those	NULL
of	NULL
the	NULL
double	NULL
octamer	NULL
site	NULL
mutant	NULL
were	NULL
obtained	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
EL4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
stimulated	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
ionomycin	NULL
and/or	NULL
PMA	NULL
stimulation	NULL
completely	NULL
disappeared	NULL
,	NULL
whereas	NULL
the	NULL
basal	NULL
activity	NULL
increased	NULL
5.3-	NULL
to	NULL
6.2-fold	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
NFAT	NULL
site	NULL
is	NULL
also	NULL
responsible	NULL
for	NULL
the	NULL
low	NULL
level	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
promoter	NULL
in	NULL
unstimulated	NULL
cells	NULL
in	NULL
addition	NULL
to	NULL
positive	NULL
regulation	NULL
after	NULL
stimulation	NULL
.	NULL

Purine	NULL
Box	NULL
Elements	NULL
The	NULL
distal	NULL
(	NULL
-291	NULL
to	NULL
-277	NULL
)	NULL
and	NULL
proximal	NULL
(	NULL
-145	NULL
to	NULL
-128	NULL
)	NULL
purine	NULL
box	NULL
sites	NULL
were	NULL
identified	NULL
through	NULL
their	NULL
high	NULL
purine	NULL
content	NULL
.	NULL

Both	NULL
purine	NULL
box	NULL
sites	NULL
contain	NULL
a	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
Ets	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
AGGAA	NULL
.	NULL

A	NULL
novel	NULL
Ets	NULL
family	NULL
member	NULL
,	NULL
Elf-1	NULL
,	NULL
binds	NULL
to	NULL
both	NULL
purine	NULL
box	NULL
sequences	NULL
.	NULL

The	NULL
distal	NULL
purine	NULL
box	NULL
is	NULL
also	NULL
the	NULL
5	NULL
``	NULL
part	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
protection	NULL
sequence	NULL
of	NULL
NFAT	NULL
.	NULL

!	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
proximal	NULL
purine	NULL
box	NULL
does	NULL
not	NULL
significantly	NULL
alter	NULL
expression	NULL
compared	NULL
to	NULL
wild	NULL
type	NULL
IL2-CAT	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
site	NULL
is	NULL
not	NULL
important	NULL
in	NULL
the	NULL
aspects	NULL
of	NULL
IL-2	NULL
gene	NULL
regulation	NULL
studied	NULL
here	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
proximal	NULL
purine	NULL
box	NULL
mutant	NULL
showed	NULL
a	NULL
decrease	NULL
in	NULL
both	NULL
the	NULL
basal	NULL
and	NULL
the	NULL
stimulated	NULL
CAT	NULL
activities	NULL
in	NULL
ELA	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
proximal	NULL
purine	NULL
box	NULL
site	NULL
in	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

The	NULL
difference	NULL
here	NULL
may	NULL
lie	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
since	NULL
Jurkat	NULL
cells	NULL
require	NULL
two	NULL
signals	NULL
for	NULL
the	NULL
IL-2	NULL
gene	NULL
induction	NULL
,	NULL
while	NULL
EL4	NULL
cells	NULL
require	NULL
only	NULL
one	NULL
signal	NULL
.	NULL
``	NULL

In	NULL
the	NULL
case	NULL
of	NULL
distal	NULL
purine	NULL
box	NULL
mutant	NULL
,	NULL
the	NULL
response	NULL
of	NULL
the	NULL
mutant	NULL
to	NULL
extracellular	NULL
stimulation	NULL
is	NULL
decreased	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
EL4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
distal	NULL
purine	NULL
box	NULL
site	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
distal	NULL
purine	NULL
box	NULL
mutant	NULL
is	NULL
increased	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
while	NULL
decreased	NULL
in	NULL
ELA	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

224	NULL
/	NULL
Zhang	NULL
and	NULL
Nabel	NULL
Plasmid	NULL
IL2-CAT	NULL
A	NULL
NFAT	NULL
IL2-CAT	NULL
anrat	NULL
[	NULL
F	NULL
B	NULL
§	NULL
4	NULL
BR	NULL
|	NULL
Stimulation	NULL
CYTOKINE	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
May	NULL
1994	NULL
:	NULL
221-228	NULL
)	NULL
Percent	NULL
conversion	NULL
0	NULL
10	NULL
-	NULL
20	NULL
830	NULL
40	NULL
50	NULL
60	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
mutation	NULL
on	NULL
the	NULL
transient	NULL
expression	NULL
of	NULL
IL2-CAT	NULL
.	NULL

Jurkat	NULL
(	NULL
A	NULL
)	NULL
or	NULL
EL4	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild	NULL
type	NULL
plasmid	NULL
(	NULL
IL2-CAT	NULL
)	NULL
or	NULL
the	NULL
NFAT	NULL
site	NULL
mutant	NULL
(	NULL
A	NULL
NFAT	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
stimulation	NULL
.	NULL

Cell	NULL
treatment	NULL
and	NULL
CAT	NULL
activity	NULL
determination	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
order	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

_	NULL
Again	NULL
,	NULL
the	NULL
difference	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
different	NULL
factors	NULL
(	NULL
possibly	NULL
species-specific	NULL
)	NULL
in	NULL
each	NULL
cell	NULL
lines	NULL
.	NULL

IL-2	NULL
kB	NULL
and	NULL
AP-1	NULL
Sites	NULL
By	NULL
sequence	NULL
comparison	NULL
with	NULL
the	NULL
k	NULL
light	NULL
chain	NULL
enhancer	NULL
of	NULL
immunoglobulins	NULL
,	NULL
the	NULL
IL-2	NULL
receptor	NULL
a-chain	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
a	NULL
«	NULL
B	NULL
site	NULL
(	NULL
-206	NULL
to	NULL
-195	NULL
)	NULL
within	NULL
the	NULL
IL-2	NULL
enhancer	NULL
was	NULL
identified	NULL
.	NULL

This	NULL
xB	NULL
site	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
with	NULL
mitogen	NULL
induced	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
and	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
mitogen-induced	NULL
activation	NULL
of	NULL
IL-2	NULL
in	NULL
both	NULL
Jurkat	NULL
cells	NULL
and	NULL
in	NULL
nontransformed	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

``	NULL
*~	NULL
``	NULL
``	NULL
In	NULL
contrast	NULL
to	NULL
these	NULL
results	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
kB	NULL
site	NULL
mutant	NULL
IL2-CAT-A	NULL
kB	NULL
was	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
in	NULL
ELA	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
activated	NULL
Jurkat	NULL
cells	NULL
,	NULL
although	NULL
the	NULL
absolute	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
kB	NULL
site	NULL
mutant	NULL
to	NULL
ionomycin	NULL
and	NULL
PMA	NULL
stimu-	NULL
lation	NULL
showed	NULL
no	NULL
difference	NULL
to	NULL
that	NULL
of	NULL
the	NULL
IL-2-CAT	NULL
plasmid	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
ionomycin	NULL
and	NULL
PMA	NULL
de-creased	NULL
,	NULL
since	NULL
the	NULL
basal	NULL
activity	NULL
increased	NULL
24.5-fold	NULL
over	NULL
IL2-CAT	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
«	NULL
B	NULL
site	NULL
's	NULL
function	NULL
is	NULL
minimal	NULL
in	NULL
EL4	NULL
cells	NULL
following	NULL
PMA	NULL
treatment	NULL
;	NULL
however	NULL
,	NULL
the	NULL
kB	NULL
site	NULL
appears	NULL
to	NULL
contribute	NULL
more	NULL
to	NULL
the	NULL
negative	NULL
control	NULL
than	NULL
to	NULL
the	NULL
mitogenic	NULL
induction	NULL
of	NULL
IL-2	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
EL4	NULL
cell	NULL
line	NULL
used	NULL
in	NULL
this	NULL
study	NULL
expresses	NULL
IL-1	NULL
receptors	NULL
at	NULL
the	NULL
cell	NULL
membrane	NULL
and	NULL
IL-2	NULL
production	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
IL-1	NULL
and	NULL
ionomycin	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
IL-1	NULL
and	NULL
ionomycin	NULL
stimulation	NULL
,	NULL
the	NULL
kB	NULL
site	NULL
mutant	NULL
showed	NULL
a	NULL
decreased	NULL
CAT	NULL
activity	NULL
while	NULL
an	NULL
AP-1	NULL
site	NULL
mutant	NULL
showed	NULL
no	NULL
difference	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
kB	NULL
site	NULL
in	NULL
the	NULL
IL-1	NULL
pathway	NULL
.	NULL

The	NULL
IL-2	NULL
enhancer	NULL
contains	NULL
an	NULL
AP-1	NULL
site	NULL
(	NULL
-186	NULL
to	NULL
-176	NULL
)	NULL
by	NULL
sequence	NULL
comparison	NULL
.	NULL

This	NULL
site	NULL
is	NULL
specifically	NULL
recognized	NULL
by	NULL
purified	NULL
AP-1	NULL
,	NULL
and	NULL
confers	NULL
IL-1	NULL
responsiveness	NULL
on	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
the	NULL
mouse	NULL
T	NULL
cell	NULL
line	NULL
LBRM	NULL
.	NULL
``	NULL

However	NULL
,	NULL
no	NULL
response	NULL
to	NULL
IL-1	NULL
Regulatory	NULL
site	NULL
function	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
/	NULL
225	NULL
A	NULL
Plasmid	NULL
Stimulation	NULL
Percent	NULL
conversion	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
m2caTt	NULL
|	NULL
{	NULL
K	NULL
NH	NULL
HH	NULL
]	NULL
+	NULL
+	NULL
B	NULL
m2acat	NULL
|B	NULL
R	NULL
NX	NULL
KK	NULL
|	NULL
+	NULL
A	NULL
Pu	NULL
.	NULL

p	NULL
1	NULL
A	NULL
Pu.d	NULL
I	NULL
Figure	NULL
4	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
purine	NULL
box	NULL
site	NULL
mutation	NULL
on	NULL
the	NULL
transient	NULL
expression	NULL
of	NULL
IL2-CAT	NULL
.	NULL

Jurkat	NULL
(	NULL
A	NULL
)	NULL
or	NULL
EL4	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild	NULL
type	NULL
plasmid	NULL
(	NULL
IL2-CAT	NULL
)	NULL
or	NULL
the	NULL
purine	NULL
box	NULL
site	NULL
mutants	NULL
(	NULL
A	NULL
Pu.p	NULL
,	NULL
or	NULL
A	NULL
Pu.d	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
stimulation	NULL
.	NULL

Cell	NULL
treatment	NULL
and	NULL
CAT	NULL
activity	NULL
determination	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
order	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
Plasmid	NULL
Stimulation	NULL
_	NULL
Percent	NULL
conversion	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
macat	NULL
|B	NULL
B	NULL
RX	NULL
HK	NULL
|	NULL
+	NULL
A	NULL
AP-1	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
the	NULL
«	NULL
B	NULL
site	NULL
and	NULL
the	NULL
AP-1	NULL
site	NULL
mutation	NULL
on	NULL
transient	NULL
expression	NULL
of	NULL
the	NULL
IL2-CAT	NULL
.	NULL

Jurkat	NULL
(	NULL
A	NULL
)	NULL
or	NULL
EL4	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild	NULL
type	NULL
plasmid	NULL
(	NULL
IL2-CAT	NULL
)	NULL
,	NULL
«	NULL
B	NULL
site	NULL
mutant	NULL
(	NULL
A	NULL
xB	NULL
)	NULL
,	NULL
or	NULL
AP-1	NULL
site	NULL
mutant	NULL
(	NULL
A	NULL
AP-1	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
stimulation	NULL
.	NULL

Cell	NULL
treatment	NULL
and	NULL
CAT	NULL
activity	NULL
determination	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
order	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

226	NULL
/	NULL
Zhang	NULL
and	NULL
Nabel	NULL
Plasmid	NULL
wzcat	NULL
|	NULL
{	NULL
R	NULL
N	NULL
NY	NULL
H	NULL
|	NULL
Stimulation	NULL
CYTOKINE	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
May	NULL
1994	NULL
;	NULL
221-228	NULL
)	NULL
Percent	NULL
conversion	NULL
0	NULL
3	NULL
6	NULL
9	NULL
12	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Responses	NULL
of	NULL
the	NULL
«	NULL
B	NULL
site	NULL
and	NULL
the	NULL
AP-1	NULL
site	NULL
mutation	NULL
to	NULL
IL-1	NULL
and	NULL
ionomycin	NULL
stimulation	NULL
,	NULL
ELA	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild	NULL
type	NULL
plasmid	NULL
(	NULL
IL2-CAT	NULL
)	NULL
,	NULL
xB	NULL
site	NULL
mutant	NULL
(	NULL
A	NULL
xB	NULL
)	NULL
,	NULL
and	NULL
AP-1	NULL
site	NULL
mutant	NULL
(	NULL
A	NULL
AP-1	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
ionomycin	NULL
and	NULL
IL-1	NULL
stimulation	NULL
.	NULL

Cell	NULL
treatment	NULL
and	NULL
CAT	NULL
activity	NULL
determination	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
order	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1.	NULL
stimulation	NULL
in	NULL
EL4	NULL
cells	NULL
was	NULL
observed	NULL
through	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
our	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
both	NULL
Jurkat	NULL
and	NULL
ELA	NULL
cell	NULL
lines	NULL
,	NULL
both	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
basal	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
mutant	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
mitogen	NULL
stimulated	NULL
CAT	NULL
activity	NULL
were	NULL
observed	NULL
,	NULL
although	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
decrease	NULL
was	NULL
not	NULL
very	NULL
large	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
AP-1	NULL
site	NULL
is	NULL
a	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
but	NULL
its	NULL
effect	NULL
is	NULL
not	NULL
as	NULL
significant	NULL
as	NULL
the	NULL
NFAT	NULL
site	NULL
or	NULL
the	NULL
octamet	NULL
sites	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
cis-acting	NULL
regulatory	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
were	NULL
elucidated	NULL
by	NULL
systematic	NULL
mutation	NULL
of	NULL
these	NULL
sites	NULL
and	NULL
testing	NULL
their	NULL
response	NULL
to	NULL
extracellular	NULL
stimulation	NULL
.	NULL

Since	NULL
the	NULL
native	NULL
IL-2	NULL
enhancer	NULL
is	NULL
relatively	NULL
weak	NULL
,	NULL
almost	NULL
all	NULL
previous	NULL
studies	NULL
on	NULL
IL-2	NULL
gene	NULL
regulation	NULL
had	NULL
used	NULL
a	NULL
heterologous	NULL
enhancer	NULL
or	NULL
promoter	NULL
.	NULL

Although	NULL
the	NULL
use	NULL
of	NULL
heterologous	NULL
enhancer	NULL
may	NULL
elevate	NULL
the	NULL
signal	NULL
level	NULL
,	NULL
it	NULL
can	NULL
also	NULL
interfere	NULL
with	NULL
the	NULL
action	NULL
of	NULL
the	NULL
regulatory	NULL
sites	NULL
,	NULL
making	NULL
interpretation	NULL
of	NULL
the	NULL
data	NULL
difficult	NULL
.	NULL

This	NULL
study	NULL
used	NULL
the	NULL
native	NULL
IL-2	NULL
enhancer	NULL
and	NULL
promoter	NULL
to	NULL
preserve	NULL
maximally	NULL
the	NULL
interactions	NULL
that	NULL
occur	NULL
at	NULL
each	NULL
site	NULL
and	NULL
between	NULL
the	NULL
DNA	NULL
and	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
approach	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
NFAT	NULL
site	NULL
,	NULL
and	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
octamer	NULL
sites	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
suppression	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
after	NULL
mitogenic	NULL
stimulation	NULL
.	NULL

Though	NULL
the	NULL
activity	NULL
of	NULL
wild	NULL
type	NULL
IL2-CAT	NULL
plasmid	NULL
in	NULL
Jurkat	NULL
cells	NULL
is	NULL
very	NULL
low	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
each	NULL
of	NULL
the	NULL
octamer	NULL
mutant	NULL
sites	NULL
in	NULL
resting	NULL
cells	NULL
is	NULL
considerably	NULL
above	NULL
background	NULL
level	NULL
,	NULL
highly	NULL
repro-ducible	NULL
,	NULL
and	NULL
therefore	NULL
not	NULL
likely	NULL
due	NULL
to	NULL
variations	NULL
in	NULL
background	NULL
of	NULL
the	NULL
CAT	NULL
assay	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
previous	NULL
findings	NULL
that	NULL
have	NULL
shown	NULL
the	NULL
proximal	NULL
octamer	NULL
site	NULL
negatively	NULL
regulates	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
when	NULL
linked	NULL
to	NULL
a	NULL
heterologous	NULL
enhancer	NULL
;	NULL
°	NULL
however	NULL
,	NULL
in	NULL
the	NULL
same	NULL
study	NULL
,	NULL
no	NULL
positive	NULL
function	NULL
was	NULL
found	NULL
for	NULL
the	NULL
proximal	NULL
octamer	NULL
site	NULL
,	NULL
probably	NULL
because	NULL
a	NULL
strong	NULL
SV40	NULL
enhancer	NULL
has	NULL
overcome	NULL
the	NULL
deficit	NULL
of	NULL
the	NULL
octamer	NULL
mu-tation	NULL
.	NULL

A	NULL
subsequent	NULL
study	NULL
,	NULL
however	NULL
,	NULL
suggested	NULL
a	NULL
positive	NULL
role	NULL
for	NULL
this	NULL
element	NULL
in	NULL
the	NULL
native	NULL
enhancer	NULL
'	NULL
``	NULL
in	NULL
mitogen-stimulated	NULL
cells	NULL
,	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
findings	NULL
presented	NULL
here	NULL
.	NULL

The	NULL
NFAT	NULL
site	NULL
is	NULL
crucial	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
mutation	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
completely	NULL
abolished	NULL
the	NULL
response	NULL
to	NULL
stimulation	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
two	NULL
octamer	NULL
sites	NULL
contributes	NULL
to	NULL
both	NULL
negative	NULL
and	NULL
positive	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
yet	NULL
full	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
achieved	NULL
only	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
octamer	NULL
sites	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
a	NULL
single	NULL
site	NULL
can	NULL
confer	NULL
two	NULL
different	NULL
functions	NULL
depending	NULL
on	NULL
the	NULL
state	NULL
of	NULL
cellular	NULL
activation	NULL
.	NULL

The	NULL
changes	NULL
in	NULL
function	NULL
of	NULL
these	NULL
regulatory	NULL
sites	NULL
may	NULL
be	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
protein	NULL
complexes	NULL
bound	NULL
to	NULL
these	NULL
sites	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
.	NULL

Although	NULL
no	NULL
difference	NULL
was	NULL
detected	NULL
from	NULL
specific	NULL
DNA-protein	NULL
binding	NULL
at	NULL
either	NULL
the	NULL
proximal	NULL
or	NULL
distal	NULL
octamer	NULL
sites	NULL
before	NULL
or	NULL
after	NULL
stimulation	NULL
,	NULL
``	NULL
``	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
these	NULL
protein	NULL
complexes	NULL
are	NULL
modified	NULL
post-translationally	NULL
after	NULL
stimulation	NULL
.	NULL

Even	NULL
though	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
complexes	NULL
did	NULL
not	NULL
change	NULL
,	NULL
such	NULL
modification	NULL
(	NULL
e.g	NULL
.	NULL

phosphorylation	NULL
)	NULL
may	NULL
alter	NULL
their	NULL
function	NULL
,	NULL
resulting	NULL
in	NULL
repression	NULL
before	NULL
stimulation	NULL
or	NULL
induction	NULL
after	NULL
stimulation	NULL
.	NULL

Another	NULL
explanation	NULL
may	NULL
involve	NULL
a	NULL
recently	NULL
described	NULL
inducible	NULL
protein	NULL
,	NULL
OAP	NULL
(	NULL
Oct-1	NULL
associated	NULL
protein	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
5	NULL
'	NULL
to	NULL
the	NULL
proximal	NULL
octamer	NULL
site	NULL
.	NULL
``	NULL

''	NULL
It	NULL
is	NULL
likely	NULL
that	NULL
octamer	NULL
binding	NULL
with	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
fac-	NULL
tor	NULL
,	NULL
Oct-1	NULL
,	NULL
in	NULL
resting	NULL
cells	NULL
is	NULL
inhibitory	NULL
to	NULL
IL-2	NULL
tran-scription	NULL
;	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
OAP	NULL
alters	NULL
the	NULL
function	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
complexes	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
NFAT-1	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
``	NULL
*	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
through	NULL
the	NULL
NFAT	NULL
site	NULL
.	NULL

Although	NULL
no	NULL
DNA-protein	NULL
interactions	NULL
were	NULL
observed	NULL
at	NULL
the	NULL
NFAT	NULL
site	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
in	NULL
vitro	NULL
DNA-protein	NULL
binding	NULL
may	NULL
not	NULL
reflect	NULL
the	NULL
in	NULL
vivo	NULL
interaction	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
a	NULL
low	NULL
affinity	NULL
DNA-protein	NULL
interaction	NULL
may	NULL
occur	NULL
at	NULL
the	NULL
NFAT	NULL
site	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
which	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
basal	NULL
repression	NULL
observed	NULL
through	NULL
this	NULL
site	NULL
.	NULL

The	NULL
distal	NULL
purine	NULL
box	NULL
site	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
negative	NULL
and	NULL
positive	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

This	NULL
purine	NULL
box	NULL
site	NULL
is	NULL
located	NULL
just	NULL
upstream	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
,	NULL
and	NULL
is	NULL
seen	NULL
as	NULL
part	NULL
of	NULL
the	NULL
DNA	NULL
footprint	NULL
of	NULL
IL-2E	NULL
.	NULL
``	NULL

'	NULL
The	NULL
effect	NULL
of	NULL
the	NULL
proximal	NULL
purine	NULL
box	NULL
site	NULL
alone	NULL
is	NULL
minor	NULL
and	NULL
differs	NULL
between	NULL
the	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

This	NULL
may	NULL
be	NULL
because	NULL
the	NULL
factors	NULL
needed	NULL
for	NULL
interactions	NULL
with	NULL
one	NULL
of	NULL
the	NULL
two	NULL
purine	NULL
box	NULL
sites	NULL
are	NULL
not	NULL
present	NULL
or	NULL
not	NULL
functional	NULL
in	NULL
one	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
since	NULL
the	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
are	NULL
representative	NULL
of	NULL
different	NULL
stages	NULL
of	NULL
T	NULL
cell	NULL
maturation	NULL
and	NULL
require	NULL
different	NULL
stimuli	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
may	NULL
be	NULL
different	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

The	NULL
«	NULL
kB	NULL
site	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

``	NULL
``	NULL
~*	NULL
>	NULL
The	NULL
«	NULL
kB	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
was	NULL
initially	NULL
defined	NULL
through	NULL
DNase	NULL
I	NULL
footprinting	NULL
at	NULL
this	NULL
region	NULL
with	NULL
stimulated	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extract	NULL
,	NULL
``	NULL
but	NULL
deletion	NULL
analysis	NULL
failed	NULL
to	NULL
detect	NULL
any	NULL
function	NULL
in	NULL
this	NULL
site	NULL
.	NULL
``	NULL

Other	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
«	NULL
B	NULL
site	NULL
is	NULL
important	NULL
for	NULL
IL-2	NULL
gene	NULL
activation	NULL
after	NULL
mitogenic	NULL
simu-lation	NULL
.	NULL

'*	NULL
'	NULL
>	NULL
>	NULL
``	NULL
*	NULL
``	NULL
``	NULL
Our	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
main	NULL
function	NULL
of	NULL
the	NULL
kB	NULL
site	NULL
is	NULL
to	NULL
keep	NULL
the	NULL
IL-2	NULL
gene	NULL
silent	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimulation	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
negative	NULL
regulatory	NULL
effect	NULL
is	NULL
conferred	NULL
through	NULL
NF-kB	NULL
p50	NULL
homodimers	NULL
since	NULL
a	NULL
previous	NULL
study	NULL
showed	NULL
that	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
parallels	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
NF-kB	NULL
p50	NULL
homodimer	NULL
to	NULL
the	NULL
«	NULL
B	NULL
site	NULL
.	NULL
``	NULL

''	NULL
In	NULL
ELA	NULL
cells	NULL
,	NULL
the	NULL
kB	NULL
site	NULL
is	NULL
not	NULL
important	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
stimulation	NULL
,	NULL
but	NULL
is	NULL
important	NULL
in	NULL
conferring	NULL
the	NULL
IL-1	NULL
responsiveness	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
redundancy	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
from	NULL
the	NULL
NFAT	NULL
and/or	NULL
other	NULL
regulatory	NULL
sites	NULL
,	NULL
can	NULL
overcome	NULL
the	NULL
requirement	NULL
for	NULL
kB	NULL
in	NULL
ELA	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
mitogen	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
AP-1	NULL
site	NULL
responded	NULL
to	NULL
PMA	NULL
to	NULL
some	NULL
extent	NULL
in	NULL
Jurkat	NULL
and	NULL
ELA	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
findings	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
has	NULL
only	NULL
weak	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL
``	NULL

Contrary	NULL
to	NULL
previous	NULL
reports	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
IL-1	NULL
pathway	NULL
in	NULL
LBRM	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
our	NULL
results	NULL
showed	NULL
that	NULL
this	NULL
AP-1	NULL
site	NULL
does	NULL
not	NULL
respond	NULL
to	NULL
IL-1	NULL
stimulation	NULL
in	NULL
ELA	NULL
cells	NULL
;	NULL
the	NULL
IL-1	NULL
responsiveness	NULL
Regulatory	NULL
site	NULL
function	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
/	NULL
227	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
xB	NULL
site	NULL
.	NULL

The	NULL
difference	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
different	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
presented	NULL
in	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

Another	NULL
AP-1	NULL
site	NULL
(	NULL
-151	NULL
to	NULL
-145	NULL
)	NULL
may	NULL
also	NULL
confer	NULL
IL-1	NULL
responsiveness	NULL
in	NULL
EL4	NULL
cells	NULL
,	NULL
since	NULL
this	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
IL-2	NULL
enhancer	NULL
is	NULL
protected	NULL
by	NULL
an	NULL
AP-1	NULL
like	NULL
factor	NULL
from	NULL
EL4	NULL
cell	NULL
extract	NULL
in	NULL
DNase	NULL
I	NULL
footprint	NULL
experiment	NULL
.	NULL
``	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
study	NULL
indicates	NULL
that	NULL
all	NULL
of	NULL
the	NULL
seven	NULL
IL-2	NULL
regulatory	NULL
sites	NULL
studied	NULL
participate	NULL
to	NULL
some	NULL
extent	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimulation	NULL
.	NULL

The	NULL
NFAT	NULL
,	NULL
the	NULL
distal	NULL
and	NULL
the	NULL
proximal	NULL
octamer	NULL
sites	NULL
having	NULL
a	NULL
silencing	NULL
effect	NULL
on	NULL
IL-2	NULL
transcription	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
however	NULL
,	NULL
these	NULL
three	NULL
sites	NULL
all	NULL
act	NULL
positively	NULL
to	NULL
induce	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
distal	NULL
and	NULL
proximal	NULL
purine	NULL
box	NULL
sites	NULL
display	NULL
different	NULL
functions	NULL
in	NULL
the	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
studied	NULL
,	NULL
Jurkat	NULL
and	NULL
EL4	NULL
.	NULL

For	NULL
the	NULL
«	NULL
B	NULL
and	NULL
the	NULL
AP-1	NULL
sites	NULL
,	NULL
these	NULL
two	NULL
sites	NULL
are	NULL
found	NULL
to	NULL
respond	NULL
to	NULL
IL-1	NULL
and	NULL
PMA	NULL
stimulation	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
findings	NULL
contribute	NULL
to	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
different	NULL
T	NULL
cell	NULL
subsets	NULL
and	NULL
during	NULL
T	NULL
cell	NULL
progressive	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Construction	NULL
The	NULL
IL2-CAT	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
inserting	NULL
an	NULL
Rsa	NULL
I	NULL
fragment	NULL
from	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
-585	NULL
to	NULL
+18	NULL
,	NULL
digested	NULL
by	NULL
Bal	NULL
31	NULL
to	NULL
eliminate	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
)	NULL
into	NULL
the	NULL
pUC-CAT	NULL
plasmid	NULL
.	NULL

All	NULL
the	NULL
mutants	NULL
were	NULL
made	NULL
using	NULL
the	NULL
site	NULL
directed	NULL
mutagenesis	NULL
technique*	NULL
``	NULL
and	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
mutated	NULL
regions	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
construction	NULL
of	NULL
the	NULL
mutants	NULL
are	NULL
:	NULL
proximal	NULL
octamer	NULL
site	NULL
,	NULL
5-GTGTA-ATATGTCTCGAGTTTTGCACC-3	NULL
'	NULL
;	NULL
distal	NULL
octamer	NULL
site	NULL
,	NULL
5'-CATACAGAAGGCGCAGCGGATCCGAATTAGA-GCTA-3	NULL
'	NULL
;	NULL
NFAT	NULL
site	NULL
,	NULL
5-A-AGGAGGAAAAATGTGC-AGTCTGCAGCGGCGTTAATTGC-3	NULL
'	NULL
;	NULL
proximal	NULL
purine	NULL
box	NULL
site	NULL
,	NULL
5-GTCATCAGGGTCCTGCGTATGAAGG-TAA-3	NULL
'	NULL
;	NULL
distal	NULL
purine	NULL
box	NULL
site	NULL
,	NULL
5-CCTTAAAGAA-GATCTTCGTCACTGTTTCAT-3	NULL
'	NULL
;	NULL
kB	NULL
site	NULL
,	NULL
5-GTAA-CAAAGATTCTAGAT-CGATACATCCATTC-3	NULL
'	NULL
;	NULL
AP-site	NULL
,	NULL
5-CTACATCCATTCGAAGCTTCTTTGGGGG-3	NULL
'	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection	NULL
Jurkat	NULL
and	NULL
EL4	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
media	NULL
(	NULL
GIBCO	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
50	NULL
U/ml	NULL
penicillin	NULL
and	NULL
50	NULL
U/ml	NULL
streptomycin	NULL
.	NULL

b-mercaptoethanol	NULL
,	NULL
50	NULL
mM	NULL
,	NULL
was	NULL
also	NULL
included	NULL
in	NULL
the	NULL
media	NULL
for	NULL
EL4	NULL
cells	NULL
.	NULL

DNA	NULL
transfection	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
previously	NULL
de-scribed	NULL
.	NULL
``	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
and	NULL
normalized	NULL
during	NULL
the	NULL
CAT	NULL
assay	NULL
.	NULL

With	NULL
these	NULL
conditions	NULL
,	NULL
co-transfection	NULL
experiments	NULL
using	NULL
RSV-luciferase	NULL
plasmid	NULL
have	NULL
shown	NULL
that	NULL
there	NULL
is	NULL
no	NULL
significant	NULL
variation	NULL
among	NULL
228	NULL
/	NULL
Zhang	NULL
and	NULL
Nabel	NULL
transfection	NULL
efficiency	NULL
in	NULL
a	NULL
single	NULL
experiment	NULL
(	NULL
Zhang	NULL
and	NULL
Nabel	NULL
,	NULL
unpublished	NULL
)	NULL
.	NULL

Plasmid	NULL
,	NULL
10	NULL
ug	NULL
,	NULL
was	NULL
used	NULL
to	NULL
transfect	NULL
10	NULL
'	NULL
cells	NULL
.	NULL

After	NULL
the	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
media	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
PMA	NULL
and	NULL
1.4	NULL
ug/ml	NULL
of	NULL
ionomycin	NULL
for	NULL
20	NULL
h	NULL
,	NULL
and	NULL
EL4	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
10	NULL
ng/	NULL
ml	NULL
of	NULL
PMA	NULL
for	NULL
12	NULL
h	NULL
,	NULL
or	NULL
1.4	NULL
pg/ml	NULL
of	NULL
ionomycin	NULL
and	NULL
15	NULL
U/ml	NULL
IL-1	NULL
for	NULL
16	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
44	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
made	NULL
after	NULL
three	NULL
rounds	NULL
of	NULL
freeze-thaw	NULL
in	NULL
ethanol/dry	NULL
ice	NULL
bath	NULL
.	NULL

The	NULL
protein	NULL
content	NULL
of	NULL
each	NULL
extract	NULL
was	NULL
quantitated	NULL
by	NULL
Bradford	NULL
assay	NULL
and	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
protein	NULL
from	NULL
each	NULL
extract	NULL
was	NULL
used	NULL
for	NULL
CAT	NULL
assay	NULL
.	NULL

Though	NULL
the	NULL
conversion	NULL
of	NULL
wild	NULL
type	NULL
IL2-CAT	NULL
plasmid	NULL
in	NULL
Jurkat	NULL
cells	NULL
is	NULL
near	NULL
the	NULL
limits	NULL
of	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
CAT	NULL
assay	NULL
,	NULL
it	NULL
nonetheless	NULL
shows	NULL
the	NULL
difference	NULL
in	NULL
CAT	NULL
activity	NULL
among	NULL
different	NULL
protein	NULL
extracts	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
from	NULL
one	NULL
experiment	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
replicates	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Smith	NULL
KA	NULL
(	NULL
1980	NULL
)	NULL
T-cell	NULL
growth	NULL
factor	NULL
.	NULL

Immunol	NULL
Rev	NULL
51:337-357	NULL
.	NULL

2	NULL
.	NULL

Stern	NULL
J	NULL
,	NULL
Smith	NULL
KA	NULL
(	NULL
1986	NULL
)	NULL
Interleukin-2	NULL
induction	NULL
of	NULL
T-cell	NULL
G1	NULL
progression	NULL
and	NULL
c-myb	NULL
expression	NULL
.	NULL

Science	NULL
233:203-206	NULL
.	NULL

3	NULL
.	NULL

Blackman	NULL
MA	NULL
,	NULL
Tiggers	NULL
MA	NULL
,	NULL
Minie	NULL
ME	NULL
,	NULL
Koshland	NULL
ME	NULL
(	NULL
1986	NULL
)	NULL
A	NULL
model	NULL
system	NULL
for	NULL
peptide	NULL
hormone	NULL
action	NULL
in	NULL
differen-tiation	NULL
:	NULL
IL-2	NULL
induces	NULL
a	NULL
B	NULL
lymphoma	NULL
to	NULL
transcribe	NULL
the	NULL
J	NULL
chain	NULL
gene	NULL
.	NULL

Cell	NULL
47:609-617	NULL
.	NULL

4	NULL
.	NULL

Watson	NULL
J	NULL
,	NULL
Gillis	NULL
$	NULL
,	NULL
Marbrook	NULL
J	NULL
,	NULL
Mochizuki	NULL
D	NULL
,	NULL
Smith	NULL
KA	NULL
(	NULL
1980	NULL
)	NULL
Biochemical	NULL
and	NULL
biological	NULL
characterization	NULL
of	NULL
lymphocyte	NULL
regulatory	NULL
molecules	NULL
I.	NULL
J	NULL
Exp	NULL
Med	NULL
150:849-861	NULL
.	NULL

5	NULL
.	NULL

Durand	NULL
DB	NULL
,	NULL
Bush	NULL
MR	NULL
,	NULL
Morgan	NULL
JC	NULL
,	NULL
Weiss	NULL
A	NULL
,	NULL
Crabtree	NULL
GR	NULL
(	NULL
1987	NULL
)	NULL
A	NULL
275	NULL
basepair	NULL
fragment	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
enhances	NULL
expression	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
165:395-407	NULL
.	NULL

6	NULL
.	NULL

Fujita	NULL
T	NULL
,	NULL
Shibuya	NULL
H	NULL
,	NULL
Ohashi	NULL
T	NULL
,	NULL
Yamanishi	NULL
K	NULL
,	NULL
Taniguchi	NULL
T	NULL
(	NULL
1986	NULL
)	NULL
Regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
:	NULL
functional	NULL
DNA	NULL
sequence	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
for	NULL
the	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
46:401-407	NULL
.	NULL

7	NULL
.	NULL

Durand	NULL
DB	NULL
,	NULL
Shaw	NULL
JP	NULL
,	NULL
Bush	NULL
MR	NULL
,	NULL
Replogle	NULL
RE	NULL
,	NULL
Balagaje	NULL
R	NULL
,	NULL
Crabtree	NULL
GR	NULL
(	NULL
1988	NULL
)	NULL
Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:1715-1724	NULL
.	NULL

8	NULL
.	NULL

Shaw	NULL
JP	NULL
,	NULL
Utz	NULL
PJ	NULL
,	NULL
Durand	NULL
DB	NULL
,	NULL
Toole	NULL
JJ	NULL
,	NULL
Emmel	NULL
EA	NULL
,	NULL
Crabtree	NULL
GR	NULL
(	NULL
1988	NULL
)	NULL
Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

9	NULL
.	NULL

Nabel	NULL
GJ	NULL
,	NULL
Gorka	NULL
C	NULL
,	NULL
Baltimore	NULL
D	NULL
(	NULL
1988	NULL
)	NULL
T-cell-specific	NULL
expression	NULL
of	NULL
interleukin	NULL
2	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
negative	NULL
regulatory	NULL
site	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:2934-2938	NULL
.	NULL

10	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Corcoran	NULL
L	NULL
,	NULL
LeBowitz	NULL
JH	NULL
,	NULL
Baltimore	NULL
D	NULL
(	NULL
1990	NULL
)	NULL
The	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
gene	NULL
contains	NULL
two	NULL
octamer-binding	NULL
sites	NULL
and	NULL
is	NULL
partially	NULL
activated	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
Oct-2	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:5464-5472	NULL
.	NULL

11	NULL
.	NULL

Thompson	NULL
CB	NULL
,	NULL
Wang	NULL
C-Y	NULL
,	NULL
Ho	NULL
I-C	NULL
,	NULL
Bohjanen	NULL
PR	NULL
,	NULL
Petryniak	NULL
B	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Miesfeldt	NULL
$	NULL
,	NULL
Zhang	NULL
L	NULL
,	NULL
Nabel	NULL
GJ	NULL
,	NULL
Karpinski	NULL
B	NULL
,	NULL
Leiden	NULL
JM	NULL
(	NULL
1992	NULL
)	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
Interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:1043-1053	NULL
.	NULL

12	NULL
.	NULL

Weiss	NULL
A	NULL
,	NULL
Wiskocil	NULL
RL	NULL
,	NULL
Stobo	NULL
JD	NULL
(	NULL
1984	NULL
)	NULL
The	NULL
role	NULL
of	NULL
T3	NULL
surface	NULL
molecules	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
two-stimulus	NULL
CYTOKINE	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
May	NULL
1994	NULL
;	NULL
221-228	NULL
)	NULL
requirement	NULL
for	NULL
IL	NULL
2	NULL
production	NULL
reflects	NULL
events	NULL
occurring	NULL
at	NULL
a	NULL
pre-translational	NULL
level	NULL
.	NULL

J	NULL
Immunol	NULL
133:123-128	NULL
.	NULL

13	NULL
.	NULL

Farrar	NULL
JJ	NULL
,	NULL
Fuller-Farrar	NULL
J	NULL
,	NULL
Simon	NULL
PL	NULL
,	NULL
Hilfiker	NULL
ML	NULL
,	NULL
Stadler	NULL
BM	NULL
,	NULL
Farrar	NULL
WL	NULL
(	NULL
1980	NULL
)	NULL
Thymoma	NULL
production	NULL
of	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
(	NULL
interleukin	NULL
2	NULL
)	NULL
.	NULL

J	NULL
Immunol	NULL
125:2555-2558	NULL
.	NULL

14	NULL
.	NULL

Baumann	NULL
G	NULL
,	NULL
Geisse	NULL
S	NULL
,	NULL
Sullivan	NULL
M	NULL
(	NULL
1991	NULL
)	NULL
Cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
both	NULL
affect	NULL
DNA	NULL
binding	NULL
of	NULL
regulatory	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
human	NULL
interleukin-2	NULL
promoter	NULL
.	NULL

New	NULL
Biol	NULL
3:270-278	NULL
.	NULL

15	NULL
.	NULL

Hoyos	NULL
B	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Bohnlein	NULL
E	NULL
,	NULL
Sieckevity	NULL
M	NULL
,	NULL
Greene	NULL
WC	NULL
(	NULL
1989	NULL
)	NULL
Kappa-B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244:457-460	NULL
.	NULL

16	NULL
.	NULL

Kang	NULL
S-M	NULL
,	NULL
Tran	NULL
A-A	NULL
,	NULL
Grilli	NULL
M	NULL
,	NULL
Lenardo	NULL
MJ	NULL
(	NULL
1992	NULL
)	NULL
NF-kB	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4+	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256:1452-1456	NULL
.	NULL

17	NULL
.	NULL

Muegge	NULL
K	NULL
,	NULL
Williams	NULL
TM	NULL
,	NULL
Kant	NULL
J	NULL
,	NULL
Karin	NULL
M	NULL
,	NULL
Chiu	NULL
R	NULL
,	NULL
Schmidt	NULL
A	NULL
,	NULL
Sienbenlist	NULL
U	NULL
,	NULL
Young	NULL
HA	NULL
,	NULL
Durum	NULL
SK	NULL
(	NULL
1989	NULL
)	NULL
Inter-leukin-1	NULL
costimulatory	NULL
activity	NULL
on	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
via	NULL
AP-1	NULL
.	NULL

Science	NULL
246:249-251	NULL
.	NULL

18	NULL
.	NULL

Mattila	NULL
PS	NULL
,	NULL
Ullman	NULL
KS	NULL
,	NULL
Fiering	NULL
S	NULL
,	NULL
McCutcheon	NULL
M	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Herzenberg	NULL
LA	NULL
(	NULL
1990	NULL
)	NULL
The	NULL
actions	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
9	NULL
;	NULL
4425-4433	NULL
.	NULL

19	NULL
.	NULL

Ullman	NULL
KS	NULL
,	NULL
Flanagan	NULL
WM	NULL
,	NULL
Edwards	NULL
CA	NULL
,	NULL
Crabtree	NULL
GR	NULL
(	NULL
1991	NULL
)	NULL
Activation	NULL
of	NULL
early	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
Oct-1	NULL
and	NULL
an	NULL
inducible	NULL
protein	NULL
,	NULL
OAP	NULL
.	NULL

Science	NULL
254:558-562	NULL
.	NULL

20	NULL
.	NULL

Riegel	NULL
JS	NULL
,	NULL
Corthesy	NULL
B	NULL
,	NULL
Flanagan	NULL
WM	NULL
,	NULL
Crabtree	NULL
GR	NULL
(	NULL
1992	NULL
)	NULL
Regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Chem	NULL
Immunol	NULL
51:266-298	NULL
.	NULL

21	NULL
.	NULL

Bohnlein	NULL
E	NULL
,	NULL
Lowenthal	NULL
JW	NULL
,	NULL
Sickevitz	NULL
M	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Franza	NULL
BR	NULL
,	NULL
Greene	NULL
WC	NULL
(	NULL
1988	NULL
)	NULL
The	NULL
same	NULL
inducible	NULL
nuclear	NULL
pro-tein	NULL
(	NULL
s	NULL
)	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
recep-tor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
53:827-836	NULL
.	NULL

22	NULL
.	NULL

Kawakami	NULL
K	NULL
,	NULL
Scheidereit	NULL
C	NULL
,	NULL
Roeder	NULL
RG	NULL
(	NULL
1988	NULL
)	NULL
Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin-enhancer-binding	NULL
protein	NULL
(	NULL
NF-kappa	NULL
B	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:4700-4704	NULL
.	NULL

23	NULL
.	NULL

Lenardo	NULL
MJ	NULL
,	NULL
Fan	NULL
C-M	NULL
,	NULL
Maniatis	NULL
T	NULL
,	NULL
Baltimore	NULL
D	NULL
(	NULL
1989	NULL
)	NULL
The	NULL
involvement	NULL
of	NULL
NF-kB	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
57:287-294	NULL
.	NULL

24	NULL
.	NULL

Briegel	NULL
K	NULL
,	NULL
Hentsch	NULL
B	NULL
,	NULL
Pfeuffer	NULL
I	NULL
,	NULL
Serfling	NULL
E	NULL
(	NULL
1991	NULL
)	NULL
One	NULL
base	NULL
pair	NULL
change	NULL
abolishes	NULL
the	NULL
T	NULL
cell-restricted	NULL
activity	NULL
of	NULL
kB-like	NULL
proto-enhancer	NULL
element	NULL
from	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

Nucl	NULL
Acids	NULL
Res	NULL
19:5929-5936	NULL
.	NULL

25	NULL
.	NULL

Hentsch	NULL
B	NULL
,	NULL
Mouzaki	NULL
A	NULL
,	NULL
Pfeuffer	NULL
I	NULL
,	NULL
Rungger	NULL
D	NULL
,	NULL
Serfling	NULL
E	NULL
(	NULL
1992	NULL
)	NULL
The	NULL
weak	NULL
,	NULL
fine-tuned	NULL
binding	NULL
of	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
contributes	NULL
to	NULL
its	NULL
T	NULL
cell-restricted	NULL
activity	NULL
.	NULL

Nucl	NULL
Acids	NULL
Res	NULL
20:2657-2665	NULL
.	NULL

26	NULL
.	NULL

Williams	NULL
TM	NULL
,	NULL
Eisenberg	NULL
L	NULL
,	NULL
Burlein	NULL
JE	NULL
,	NULL
Norris	NULL
CA	NULL
,	NULL
Pancer	NULL
S	NULL
,	NULL
Yao	NULL
D	NULL
,	NULL
Burger	NULL
S	NULL
,	NULL
Kamoun	NULL
M	NULL
,	NULL
Kant	NULL
JA	NULL
(	NULL
1988	NULL
)	NULL
Two	NULL
regions	NULL
within	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
promoter	NULL
are	NULL
important	NULL
for	NULL
inducible	NULL
IL-2	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
141:662-666	NULL
.	NULL

27	NULL
.	NULL

Serfling	NULL
E	NULL
,	NULL
Barthelmas	NULL
R	NULL
,	NULL
Pfeuffer	NULL
I	NULL
,	NULL
Schenk	NULL
B	NULL
,	NULL
Zarius	NULL
S	NULL
,	NULL
Swoboda	NULL
R	NULL
,	NULL
Mercurio	NULL
F	NULL
,	NULL
Karin	NULL
M	NULL
(	NULL
1989	NULL
)	NULL
Ubiquitous	NULL
and	NULL
lympho-cyte-specific	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
mouse	NULL
interleukin	NULL
2	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
8:465-473	NULL
.	NULL

28	NULL
.	NULL

Nabel	NULL
G	NULL
,	NULL
Baltimore	NULL
D	NULL
(	NULL
1987	NULL
)	NULL
An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
326:711-713	NULL
.	NULL

29	NULL
.	NULL

Leung	NULL
K	NULL
,	NULL
Nabel	NULL
GJ	NULL
(	NULL
1988	NULL
)	NULL
HTLV-I	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-kB-like	NULL
factor	NULL
.	NULL

Nature	NULL
333:776-778	NULL
.	NULL

